Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
NCT02046135 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2022-11-02
Summary
The proposed study will investigate the effect of sodium bicarbonate on the prevention of acute kidney injury in children undergoing cardiac surgery with cardio-pulmonary bypass. The investigators hypothesize that the occurrence of acute kidney injury will be less in children treated with sodium bicarbonate in the perioperative period when compared to placebo. The specific aims of this proposal are as follows:
1\. To institute a prospective, randomized, double-blinded, placebo-controlled trial in pediatric subjects undergoing cardiac surgery to determine the efficacy of sodium bicarbonate on prevention of acute kidney injury as measured by pRIFLE criteria. 2. To examine whether treatment with sodium bicarbonate modifies the duration of acute kidney injury, fluid balance, hospital length of stay, need for dialysis, and progression to kidney failure. 3. To determine the relevance of NGAL as a biomarker to predict development of acute kidney injury.
Conditions
- Acute Kidney Injury
- Congenital Heart Disease
Interventions
- DRUG
-
Sodium Bicarbonate
- DRUG
-
Sodium Chloride
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Principal Investigators
-
James Schneider, MD · Cohen Children's Medical Center of New York
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2017-06-30
- Completion
- 2017-07-22
Countries
- United States
Study Locations
More Related Trials
-
Effect of Varied Dialysate Bicarbonate Levels on Phosphate and Potassium Removal
NCT01930370 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)
NCT02692378 ·Status: COMPLETED ·Phase: PHASE4
-
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
NCT06545461 ·Status: COMPLETED ·Phase: NA
-
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
NCT06237712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
NCT07231900 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
NCT00741156 ·Status: COMPLETED ·Phase: PHASE3
-
Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension
NCT07212686 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Cardiovascular Protective Effect of Spironolactone in Hemodialysis
NCT00277693 ·Status: UNKNOWN ·Phase: PHASE4
-
Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate
NCT06270134 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating Subjects With Distal Renal Tubular Acidosis
NCT03644706 ·Status: TERMINATED ·Phase: PHASE3
-
H+ Mobilization With Dialysate Bicarbonate Variation
NCT04020757 ·Status: TERMINATED ·Phase: PHASE2
-
Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
NCT04600323 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure
NCT02031354 ·Status: COMPLETED ·Phase: NA
-
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS
NCT07178964 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
NCT03941483 ·Status: COMPLETED ·Phase: PHASE2
-
Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction
NCT00575484 ·Status: TERMINATED ·Phase: PHASE2
-
Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study
NCT02299726 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
NCT00004767 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
NCT04727528 ·Status: TERMINATED ·Phase: PHASE3
-
Chronotherapy in Children With Chronic Kidney Disease
NCT05353335 ·Status: WITHDRAWN ·Phase: NA
-
Pulmonary Hypertension Prevention in Hemodialysis
NCT01350687 ·Status: UNKNOWN
-
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
NCT00876876 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia
NCT02020278 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
NCT02896309 ·Status: COMPLETED ·Phase: NA
-
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
NCT03813407 ·Status: RECRUITING ·Phase: PHASE3